INDRAMEDCO.NS(INDRAMEDCO.NS)
INDRAMEDCO.NS
No analyst ratings available
No analyst price targets available for INDRAMEDCO.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $15.77B | $16.88B | $8.45B | $8.97B | $9.87B |
| Low | $15.77B | $16.88B | $8.45B | $8.97B | $9.87B |
| High | $15.77B | $16.88B | $8.45B | $8.97B | $9.87B |
| EBITDA Avg | $4.35B | $4.66B | $2.33B | $2.48B | $2.73B |
| Low | $4.35B | $4.66B | $2.33B | $2.48B | $2.73B |
| High | $4.35B | $4.66B | $2.33B | $2.48B | $2.73B |
| EBIT Avg | $4.04B | $4.33B | $2.17B | $2.30B | $2.53B |
| Low | $4.04B | $4.33B | $2.17B | $2.30B | $2.53B |
| High | $4.04B | $4.33B | $2.17B | $2.30B | $2.53B |
| Net Income Avg | $2.07B | $2.26B | $478M | $479M | $531M |
| Low | $2.07B | $2.26B | $478M | $479M | $531M |
| High | $2.07B | $2.26B | $478M | $479M | $531M |
| EPS Avg | $22.60 | $24.60 | $5.21 | $5.22 | $5.79 |
| Low | $22.60 | $24.60 | $5.21 | $5.22 | $5.79 |
| High | $22.60 | $24.60 | $5.21 | $5.22 | $5.79 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |